Subcutaneous Botulinum Toxin for Chronic Post-Thoracotomy Pain

Pain Practice

Volumn 13, Issue 3, 2013, Pages 231-234

  Fabregat, Gustavo ^a   Asensio Samper, Juan M ^a   Palmisani, Stefano ^a   Villanueva Pérez, Vicente L ^a   De Andrés, José ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Botulinum toxin; Chronic post thoracotomy pain; Neuropathic pain; Subcutaneous

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; CAPSAICIN; DIPYRONE; DULOXETINE; GABAPENTIN; MORPHINE; PARACETAMOL; STEROID; TIOTROPIUM BROMIDE;

AGED; ALLODYNIA; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; CHRONIC POSTTHORACOTOMY PAIN; DRUG TREATMENT FAILURE; HUMAN; HYPERALGESIA; LUNG EMPHYSEMA; LUNG NODULE; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MALE; NERVE BLOCK; NEUROLOGIC EXAMINATION; NEUROLYSIS; NEUROPATHIC PAIN; POSTOPERATIVE PAIN; SCAR; THORACOTOMY; VISUAL ANALOG SCALE;

EID: 84874795700     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2012.00569.x     Document Type: Article

References (28)

1. Strebel BM, Ross S. Chronic post-thoracotomy pain syndrome. CMAJ. 2007;9:1027.
2. Pluijms WA, Steegers MAH, Verhagen AFTM, et al.Chronic post-thoracotomy pain: a retrospective study. Acta Anaesthesiol Scand. 2006;50:804-808.
3. Dajczman E, Gordon A, Kreisman H, Wolkove N. Long-term postthoracotomy pain. Chest. 1991;99:270-274.
4. Dworkin RH, O'Connor AB, Backonja M, et al.Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-251.
5. Jost WH. Other indications of botulinum toxin therapy. Eur J Neurol. 2006;13(suppl 1):65-69.
6. Ruiz Huete C, Bermejo PE. Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia. Neurologia. 2008;23:259-262.
7. Treede RD, Jensen TS, Campbell JN, et al.Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630-1635.
8. Liu HT, Tsai SK, Kao MC, Hu JS. Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia. Pain Med. 2006;7:89-91.
9. Sotiriu E, Apalla Z, Panagiotidou D, Ioannidis D. Severe post-herpetic neuralgia succesfully treated with botulinum toxin A: three case reports. Acta Derm Venereol. 2009;889:214-215.
10. Xiao L, Mackey S, Hui H, et al.Subcutaneous injection of botulinum toxin A is beneficial in postherpetic neuralgia. Pain Med. 2010;11:1827-1833.
11. Jabbari B, Maher N, Difazio MP. Botulinum toxin A improved burning pain and allodynia in two patients with spinal cord pathology. Pain Med. 2003;4:206-210.
12. Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol. 2008;64:274-283.
13. Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002;3:21-27.
14. Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005;65:1306-1308.
15. Yuan RY, Sheu JJ, Yu JM, et al.Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology. 2009;72:1473-1478.
16. Apfel SC. Botulinum toxin for neuropathic pain?. Neurology. 2009;72:1456-1457.
17. Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol. 2009;65:348-351.
18. Kapural L, Stillman M, Kapural M, et al.Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series. Pain practice. 2007;7:337-340.
19. Wildgaard K, Ravn J, Kehlet H. Chronic post-thoracotomy pain: a critical review of pathogenic mechanisms and strategies for prevention. Eur J Cardiothorac Surg. 2009;36:170-180.
20. Maguire MF, Latter JA, Mahajan R, Beggs FD, Duffy JP. A study exploring the role of intercostal nerve damage in chronic pain alter thoracic surgery. Eur J Cardiothorac Surg. 2006;29:873-879.
21. Steegers MA, Snik DM, Verhagen AF, Van der Drift MA, Wilder-Smith OH. Only half of the chronic pain after thoracic surgery shows a neuropathic component. J Pain. 2008;9:955-961.
22. Yaraskavitch M, Leonard T, Herzog W. Botox produces functional weakness in non-injected muscles adjacent to the target muscle. J Biomech. 2008;41:897-902.
23. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;2:125-133.
24. Smith CP, Vemulakonda VM, Kiss S, Boone TB, Somogyi GT. Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation≈ffect of botulinum toxin A. Neurochem Int. 2005;47:291-297.
25. Gazerani P, Pedersen NS, Staahl C, et al.Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain. 2009;141:60-69.
26. Tugnoli V, Capone JG, Eleopra R, et al.Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilation in human skin. Pain. 2007;130:76-83.
27. Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M. Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci. 2008;28:3689-3696.
28. Byrnes ML, Thickbroom GW, Wilson SA, et al.The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection. Brain. 1998;5(Pt 5):977-988.